| 2026-08-06 | Press release | Ligand Reports Second Quarter 2026 Financial Results |
| 2026-08-06 | Earnings deck | Ligand Second Quarter 2026 Earnings Call |
| 2026-08-06 | Press release | Press Release |
| 2026-07-23 | Press release | Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026 |
| 2026-07-14 | Press release | Download , Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty |
| 2026-07-14 | Press release | Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets |
| 2026-06-23 | Press release | Download , Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering, June 23, 2026, (opens in |
| 2026-06-22 | Press release | Download , Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031, June 22, 2026, (open |
| 2026-06-10 | Press release | Ligand Announces 2026 Investor Day in New York City |
| 2026-05-27 | Press release | Download , Ligand to Participate in June Investor Conferences, May 27, 2026, (opens in new window) |
| 2026-05-27 | Press release | Ligand to Participate in June Investor Conferences |
| 2026-05-07 | Press release | Press Release |
| 2026-05-07 | Earnings deck | Presentation
of Q1 2026, PDF file, (opens in new window) |
| 2026-05-07 | Press release | Download
(opens in new window) |
| 2026-05-05 | Press release | Download , Ligand to Participate in May Investor Conferences, May 5, 2026, (opens in new window) |
| 2026-05-05 | Press release | Ligand to Participate in May Investor Conferences |
| 2026-04-27 | Press release | Download , Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a L |
| 2026-04-27 | Presentation | PRESENTATION Open Event Link, PDF file, April 27, 2026, (opens in new window) |
| 2026-04-27 | Press release | Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biop |
| 2026-04-22 | Press release | Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-22 | Press release | Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-14 | Press release | Download , Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS, April 14, |
| 2026-04-14 | Press release | Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS |
| 2026-03-26 | Press release | Download , Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team, March 26, 2026, (o |
| 2026-03-04 | Press release | Download , Ligand to Participate in March Investor Conferences, March 4, 2026, (opens in new window) |
| 2026-02-26 | Press release | Download , Ligand Reports Fourth Quarter and Full Year 2025 Financial Results, February 26, 2026, (opens in new window) |
| 2026-02-26 | Earnings deck | Presentation Open Event Link, PDF file, February 26, 2026, (opens in new window) |
| 2026-02-26 | Press release | Ligand Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-12 | Press release | Download , Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, February 12, 2026, |
| 2026-02-12 | Press release | Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 |
| 2026-02-04 | Press release | Download , Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, February 4, 2026, (open |
| 2025-12-09 | Press release | Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance |
| 2025-11-06 | Press release | Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance |
| 2025-11-05 | Earnings deck | Presentation of Q3 2025 Press Release, (opens in new window) |
| 2025-10-30 | Press release | Ligand to Participate in November Investor Conferences |
| 2025-10-23 | Press release | Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 |
| 2025-10-16 | Press release | Ligand to Host Investor Day on December 9, 2025 |
| 2025-10-09 | Press release | Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Pati |
| 2025-08-19 | Press release | Ligand to Participate in September Investor Conferences |
| 2025-08-14 | Press release | Ligand Announces Closing of Convertible Senior Notes Offering |